The goal of Thorn Medical is to become a global leader in the provision of personalised medicine, specifically cell therapies. Our initial focus is in the delivery of autologous cell therapies with the highest patient demand; hair, skin and Joint & Spine. Our services will be delivered via a combination of direct clinic operations and licenced affiliates in Europe, N America & Middle East.
Our philosophy is to support the long-term well-being of our patients by creating a lifetime relationship with the TM group. To enable a continuous client engagement, we will build out our global client contact and logistics services.
Key to our ongoing differentiation will be our holistic approach to well-being and a continuing investment in new techniques, products and services to support the cell therapy sector. This positioning will be underpinned by our commitment to quality outcomes and education; both practitioners and patients. A dedicated training facility is being planned.
Thorn Medical understands how to create value for investors, healthcare practitioners and patients. Our renewed focus on cell therapy will facilitate growth via carefully targeted acquisitions as well as by scaling our clinical operations. This growth will be led by a highly experienced, healthcare focussed & globally diverse team.